Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeles Alvarez Secord

Showing results (91-100 of 239) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancerJaniel M Cragun, Laura J Havrilesky, Brian Calingaert, et al.
Gynecologic Oncology|September 22, 2009
Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group studyElizabeth L Jewell, Kathleen M Darcy, Alan Hutson, et al.
Gynecologic Oncology|January 13, 2009
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group studyJennifer M Rubatt, Kathleen M Darcy, Alan Hutson, et al.
Gynecologic Oncology|March 16, 2007
Outcomes in surgical stage I uterine papillary serous carcinomaLaura J Havrilesky, Angeles Alvarez Secord, Victoria Bae-Jump, et al.
Gynecologic Oncology|June 4, 2015
Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysisRebecca Previs, Charles A Leath, Robert L Coleman, et al.
Gynecologic Oncology Reports|June 30, 2016
Tumor grade and chemotherapy response in endometrioid endometrial cancerBrittany A Davidson, Jonathan Foote, Leslie H Clark, et al.
Gynecologic Oncology|January 15, 2008
Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group studyAngeles Alvarez Secord, John A Blessing, Deborah K Armstrong, et al.
Gynecologic Oncology|January 16, 2009
The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinomaNikki L Neubauer, Laura J Havrilesky, Brian Calingaert, et al.
Oxidative Medicine and Cellular Longevity|April 5, 2021
H<sub>2</sub>O<sub>2</sub>-Driven Anticancer Activity of Mn Porphyrins and the Underlying Molecular PathwaysInes Batinic-Haberle, Artak Tovmasyan, Zhiqing Huang, et al.
American Journal of Obstetrics and Gynecology|April 26, 2011
Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancerJason C Barnett, Laura J Havrilesky, Amy E Bondurant, et al.
Pageof 24

Showing results (91-100 of 239) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancerJaniel M Cragun, Laura J Havrilesky, Brian Calingaert, et al.
Gynecologic Oncology|September 22, 2009
Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group studyElizabeth L Jewell, Kathleen M Darcy, Alan Hutson, et al.
Gynecologic Oncology|January 13, 2009
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group studyJennifer M Rubatt, Kathleen M Darcy, Alan Hutson, et al.
Gynecologic Oncology|March 16, 2007
Outcomes in surgical stage I uterine papillary serous carcinomaLaura J Havrilesky, Angeles Alvarez Secord, Victoria Bae-Jump, et al.
Gynecologic Oncology|June 4, 2015
Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysisRebecca Previs, Charles A Leath, Robert L Coleman, et al.
Gynecologic Oncology Reports|June 30, 2016
Tumor grade and chemotherapy response in endometrioid endometrial cancerBrittany A Davidson, Jonathan Foote, Leslie H Clark, et al.
Gynecologic Oncology|January 15, 2008
Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: a Gynecologic Oncology Group studyAngeles Alvarez Secord, John A Blessing, Deborah K Armstrong, et al.
Gynecologic Oncology|January 16, 2009
The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinomaNikki L Neubauer, Laura J Havrilesky, Brian Calingaert, et al.
Oxidative Medicine and Cellular Longevity|April 5, 2021
H<sub>2</sub>O<sub>2</sub>-Driven Anticancer Activity of Mn Porphyrins and the Underlying Molecular PathwaysInes Batinic-Haberle, Artak Tovmasyan, Zhiqing Huang, et al.
American Journal of Obstetrics and Gynecology|April 26, 2011
Adverse events associated with laparoscopy vs laparotomy in the treatment of endometrial cancerJason C Barnett, Laura J Havrilesky, Amy E Bondurant, et al.
Pageof 24